Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"
Published: 10 June 2021| Version 1 | DOI: 10.17632/6yrdmwydzj.1
Contributor:
Manabu OdaDescription
Supplementary Information and Results - Nakagawa H, et al. Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.
Files
Categories
Clinical Trial, Pediatric Dermatology, Atopic Dermatitis, Eczema, Topical Treatment, Pruritus, Janus Kinase